Peter M. Hecht - Nov 30, 2023 Form 4 Insider Report for Cyclerion Therapeutics, Inc. (CYCN)

Role
Director, 10%+ Owner
Signature
/s/ Peter M Hecht
Stock symbol
CYCN
Transactions as of
Nov 30, 2023
Transactions value $
$0
Form type
4
Date filed
12/4/2023, 04:05 PM
Previous filing
May 22, 2023
Next filing
Jan 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYCN Common Stock Award $0 +20K +6.11% $0.00 347K Nov 30, 2023 Direct F1
transaction CYCN Common Stock Award $0 +15K +4.32% $0.00 362K Dec 1, 2023 Direct F2
holding CYCN Common Stock 24 Nov 30, 2023 The 2000 Trust for Alexis Mae Hecht F3
holding CYCN Common Stock 24 Nov 30, 2023 The 2000 Trust for Malcolm Peter Hecht F3
holding CYCN Common Stock 24 Nov 30, 2023 The 2000 Trust for Zoe Niovi Hecht F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted 20,000 shares of restricted stock pursuant to the Cyclerion Therapeutics, Inc. 2019 Equity Incentive Plan. 2,500 of the shares vest immediately and the remaining 17,500 shares are subject to vesting ratably over a 42-month period, provided that the Reporting Person remains as a director of Cyclerion Therapeutics, Inc. on such applicable vesting date, subject to certain exemptions.
F2 The Reporting Person was granted 15,000 shares of restricted stock pursuant to the Cyclerion Therapeutics, Inc. 2019 Equity Incentive Plan. These 15,000 shares are subject to vesting over a 48- month period, provided that the Reporting Person remains a consultant to the Cyclerion Therapeutics or a member of the board of directors of Cyclerion Therapeutics, Inc. on such applicable vesting date, subject to certain exemptions.
F3 These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose.